Statistik Asas
| CIK | 1805385 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Evolv Technologies Holdings, Inc. - Equity Warrant
SEC Filings (Chronological Order)
Halaman ini menyediakan senarai kronologi lengkap bagi Pemfailan SEC, tidak termasuk pemfailan pemilikan yang kami sediakan di tempat lain.
| August 14, 2025 |
Exhibit 99.1 Evolv Technology Reports Second Quarter Financial Results — Company Raises Revenue Growth Outlook for 2025 to 27%-30% — •Q2'25 Revenue of $32.5 million, up 29% year-over-year •Q2'25 Ending ARR1 of $110.5 million, up 27% year-over-year •Q2'25 Net Loss of $(40.5) million, with Net Profit Margin of (125)% •Q2'25 Adjusted EBITDA2 of $2.0 million, with Adjusted EBITDA Margin2 of 6% •Q2'25 |
|
| August 14, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 00 |
|
| August 14, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 14, 2025 Evolv Technologies Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39417 84-4473840 (State or other jurisdiction of incorporation) ( |
|
| July 30, 2025 |
Exhibit 10.1 CREDIT, SECURITY AND GUARANTY AGREEMENT dated as of July 29, 2025 by and among EVOLV TECHNOLOGIES, INC., as Borrower and any additional borrower that hereafter becomes party hereto, each as Borrower, and collectively as Borrowers, and EVOLV TECHNOLOGIES HOLDINGS, INC., as a Guarantor, and any guarantor that hereafter becomes party hereto, each as Guarantor, and collectively as Guarant |
|
| July 30, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (date of earliest event reported): July 29, 2025 Evolv Technologies Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39417 84-4473840 (State or other jurisdiction of incorporation) (Co |
|
| July 30, 2025 |
Exhibit 99.1 Evolv Technology Secures Up to $75 Million in Non-Dilutive Debt Financing – New Facility Supports Growing Demand for Company’s Long Term Subscription Model – Waltham, Massachusetts – July 30, 2025 – Evolv Technologies Holdings, Inc (NASDAQ: EVLV), a leading security technology company pioneering AI-based solutions designed to help create safer experiences, today announced that it has |
|
| July 1, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): July 1, 2025 Evolv Technologies Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39417 84-4473840 (State or other jurisdiction of incorporation) (Com |
|
| July 1, 2025 |
As filed with the Securities and Exchange Commission on July 1, 2025 TABLE OF CONTENTS As filed with the Securities and Exchange Commission on July 1, 2025 Registration No. |
|
| June 23, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): June 20, 2025 Evolv Technologies Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39417 84-4473840 (State or other jurisdiction of incorporation) (Co |
|
| June 2, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM SD SPECIALIZED DISCLOSURE REPORT Evolv Technologies Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39417 84-4473840 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.) 500 Totten Pond Road, 4th Floor Waltham, Massachusetts 02451 (Add |
|
| June 2, 2025 |
Exhibit 1.01 to Form SD Evolv Technologies Holdings, Inc. Conflict Minerals Report For the Reporting Period January 1, 2024 to December 31, 2024 This Conflict Minerals Report (“CMR”) has been prepared by Evolv Technologies Holdings, Inc. (herein referred to, alternatively, as “Evolv,” “we” and “our”). This CMR for the reporting period January 1, 2024 to December 31, 2024 has been prepared in accor |
|
| May 20, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 0 |
|
| May 20, 2025 |
Form of Market-Based Stock Unit Award Agreement under the 2021 Incentive Award Plan Exhibit 10.1 EVOLV TECHNOLOGIES HOLDINGS, INC. 2021 INCENTIVE AWARD PLAN RESTRICTED STOCK UNIT GRANT NOTICE Capitalized terms not specifically defined in this Restricted Stock Unit Grant Notice (the “Grant Notice”) have the meanings given to them in the Evolv Technologies Holdings, Inc. 2021 Incentive Award Plan (as amended from time to time, the “Plan”). Evolv Technologies Holdings, Inc. (the “Co |
|
| May 20, 2025 |
Exhibit 99.1 Evolv Technology Reports First Quarter Financial Results — Company Surpasses 6,600 Total Subscriptions — — Company Expects Revenue Growth of 20%-25% with Positive Full Year Adjusted EBITDA in 2025 — •Q1'25 Revenue of $32.0 million, up 44% year-over-year •Q1'25 Ending ARR1 of $106.0 million, up 34% year-over-year •Q1'25 Net Loss of $(1.7) million, compared to $(11.3) million in Q1'24 • |
|
| May 20, 2025 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 20, 2025 Evolv Technologies Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39417 84-4473840 (State or other jurisdiction of incorporation) (Com |
|
| May 15, 2025 |
SEC FILE NUMBER 001-39417 CUSIP NUMBER 30049H102 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| April 30, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. |
|
| April 30, 2025 |
TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. |
|
| April 28, 2025 |
Executive Officer Compensation Recovery Policy Exhibit 97 EVOLV TECHNOLOGIES HOLDINGS, INC. EXECUTIVE OFFICER COMPENSATION RECOVERY POLICY (Adopted and approved on January 21, 2025 and effective as of January 21, 2025) 1.Purpose Evolv Technologies Holdings, Inc. (collectively with its subsidiaries, the “Company”) is committed to promoting high standards of honest and ethical business conduct and compliance with applicable laws, rules and regul |
|
| April 28, 2025 |
Exhibit 99.1 Evolv Technology Completes Restatement of Previously Issued Financial Statements and Reports Third Quarter, Fourth Quarter and Full Year 2024 Financial Results — Company Regains Compliance with SEC Reporting and NASDAQ Listing Requirements — — Company Achieves Positive Adjusted EBITDA1 in Q4'24 — •Q4'24 Revenue of $29.1 million, up 41% year-over-year •Q4'24 Ending ARR2 of $99.4 millio |
|
| April 28, 2025 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): April 28, 2025 Evolv Technologies Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39417 84-4473840 (State or other jurisdiction of incorporation) (C |
|
| April 28, 2025 |
Exhibit 21.1 LIST OF SUBSIDIARIES The following is a list of the direct and indirect subsidiaries of Evolv Technologies Holdings, Inc., that is current as of December 31, 2024: Subsidiaries Jurisdiction Evolv Technologies, Inc. United States Evolv Technology UK Ltd. United Kingdom Give Evolv LLC United States |
|
| April 28, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-39417 EVOLV TECHNOLOGIES HOLDIN |
|
| April 28, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file numbe |
|
| April 28, 2025 |
Insider Trading Compliance Policy Exhibit 19.1 Evolv Technologies Holdings, Inc. Insider Trading Compliance Policy This Insider Trading Compliance Policy (this “Policy”) consists of seven sections: •Section I provides an overview of persons covered by this Policy and Policy administration; •Section II sets forth the policies of the Company prohibiting insider trading; •Section III explains insider trading; •Section IV consists of |
|
| April 23, 2025 |
Evolv Technology Appoints Chris Kutsor as Chief Financial Officer –Evolv Welcomes Proven High-Tech Public Company CFO as Company Enters New Stage of Growth– WALTHAM, Mass. |
|
| April 23, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): April 21, 2025 Evolv Technologies Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39417 84-4473840 (State or other jurisdiction of incorporation) (C |
|
| April 23, 2025 |
Offer Letter between Evolv Technologies Holdings, Inc. and George C. Kutsor Exhibit 10.1 April 21, 2025 George C. Kutsor [PERSONAL CONTACT INFORMATION REDACTED] Re: Offer Letter of Employment Dear Chris: On behalf of Evolv Technologies Holdings, Inc. (the “Company”), I am delighted to offer you a position with the Company. We hope that you choose to join us and be part of our important mission to make the world a safer and more enjoyable place to work, learn, and play. St |
|
| April 22, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): April 16, 2025 Evolv Technologies Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39417 84-4473840 (State or other jurisdiction of incorporation) (C |
|
| April 22, 2025 |
Exhibit 99.1 Evolv Receives Expected Nasdaq Delinquency Notification - No Immediate Effect on the Company’s Securities Listed on Nasdaq - Waltham, Massachusetts – April 22, 2025 – Evolv Technologies Holdings, Inc. (NASDAQ: EVLV), a leading security technology company pioneering AI-based solutions designed to create safer experiences, today announced it received an expected delinquency notification |
|
| March 31, 2025 |
SEC FILE NUMBER 001-39417 CUSIP NUMBER 30049H102 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| February 4, 2025 |
Evolv Technology Announces the Appointment of Richard Shapiro as a New Independent Director Exhibit 99.1 Investor Relations: Brian Norris Senior Vice President of Finance and Investor Relations [email protected] Media Relations: Alex Ozerkis Vice President of Corporate Communications [email protected] Evolv Technology Announces the Appointment of Richard Shapiro as a New Independent Director Waltham, Massachusetts – February 4, 2025 – Evolv Technologies Holdings, Inc |
|
| February 4, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 31, 2025 Evolv Technologies Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39417 84-4473840 (State or other jurisdiction of incorporation) |
|
| January 24, 2025 |
Exhibit 99.1 Investor Relations: Brian Norris Senior Vice President of Finance and Investor Relations [email protected] Media Relations: Alex Ozerkis Vice President of Corporate Communications [email protected] Evolv Technology Announces Appointment of Chief Revenue Officer – Company Welcomes 20 Year Motorola Sales Leader to Drive and Accelerate Revenue Growth – Waltham, Massa |
|
| January 24, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 21, 2025 Evolv Technologies Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39417 84-4473840 (State or other jurisdiction of incorporation) |
|
| January 23, 2025 |
Exhibit 99.1 Investor Relations: Brian Norris Senior Vice President of Finance and Investor Relations [email protected] Media Relations: Alex Ozerkis Vice President of Corporate Communications [email protected] Evolv Technology Provides Business Update – Company Reaffirms Outlook for Positive Adjusted EBITDA1 by Q2 2025 – – Company Provides Update on Restatement Effort and Reg |
|
| January 23, 2025 |
Evolv Technologies Holdings Inc Exhibit 99.2 Evolv Technologies Holdings Inc Transcript of Chief Executive Officer Prepared Remarks January 23, 2025 Presenter John Kedzierski Transcript: Hello, my name is John Kedzierski and I'm the CEO of Evolv Technology. On behalf of all the employees of Evolv, we wish you and your loved ones a happy and healthy new year. We are excited about 2025, which we see as a year of inflection for the |
|
| January 23, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 21, 2025 Evolv Technologies Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39417 84-4473840 (State or other jurisdiction of incorporation) |
|
| December 23, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 20, 2024 Evolv Technologies Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39417 84-4473840 (State or other jurisdiction of incorporation) |
|
| December 12, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 10, 2024 Evolv Technologies Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39417 84-4473840 (State or other jurisdiction of incorporation) |
|
| December 9, 2024 |
Evolv Technology Appoints John Kedzierski as Chief Executive Officer, President, and Director Exhibit 99.1 Investor Relations: Brian Norris Senior Vice President of Finance and Investor Relations [email protected] Evolv Technology Appoints John Kedzierski as Chief Executive Officer, President, and Director Waltham, Massachusetts – December 9, 2024 – Evolv Technology (“Evolv” or the “Company”) (NASDAQ: EVLV), a leading security technology company pioneering AI-based solutions desi |
|
| December 9, 2024 |
Offer Letter between Evolv Technologies Holdings, Inc. and John Kedzierski Exhibit 10.1 December 6, 2024 John Kedzierski [PERSONAL CONTACT INFORMATION REDACTED] Re: Offer Letter of Employment Dear John: On behalf of Evolv Technologies Holdings, Inc. (the “Company”), I am delighted to offer you a position with the Company. We hope that you choose to join us and be part of our important mission to make the world a safer and more enjoyable place to work, learn, and play. St |
|
| December 9, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 6, 2024 Evolv Technologies Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39417 84-4473840 (State or other jurisdiction of incorporation) |
|
| November 22, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 21, 2024 Evolv Technologies Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39417 84-4473840 (State or other jurisdiction of incorporation) |
|
| November 22, 2024 |
Exhibit 99.1 Evolv Receives Expected Nasdaq Delinquency Notification No Immediate Effect on the Company’s Securities Listed on Nasdaq Waltham, Massachusetts – November 22, 2024 – Evolv Technology (“Evolv” or the “Company”) (NASDAQ: EVLV), a leading security technology company pioneering AI-based solutions designed to create safer experiences, today announced it received an expected delinquency not |
|
| November 21, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 20, 2024 Evolv Technologies Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39417 84-4473840 (State or other jurisdiction of incorporation) |
|
| November 21, 2024 |
Exhibit 99.1 FOR IMMEDIATE RELEASE: Evolv Technology Announces the Results of Its Internal Investigation Reaffirms Revenue Recognition Impact of $4 to $6 million Ending Cash Position of Approximately $56 Million as of September 30, 2024, Consistent with Internal Forecasts Announces Remedial Actions and Organizational Changes, Including the Resignation of the Company’s Chief Financial Officer Hires |
|
| November 13, 2024 |
SEC FILE NUMBER 001-39417 CUSIP NUMBER 30049H102 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| October 31, 2024 |
Exhibit 99.1 Investor Relations: Brian Norris Senior Vice President of Finance and Investor Relations [email protected] Evolv Technology Announces Leadership Change Michael Ellenbogen, Co-Founder, Chief Innovation Officer and Board Member, Named Interim President and CEO Board Continues Ongoing Search for New CEO Waltham, Massachusetts – October 31, 2024 – Evolv Technology (“Evolv” or th |
|
| October 31, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 30, 2024 Evolv Technologies Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39417 84-4473840 (State or other jurisdiction of incorporation) |
|
| October 25, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 24, 2024 Evolv Technologies Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39417 84-4473840 (State or other jurisdiction of incorporation) |
|
| October 25, 2024 |
Exhibit 99.1 Investor Relations: Brian Norris Senior Vice President of Finance and Investor Relations [email protected] The Board of Evolv Technology Determines that Certain Financial Statements Should Not Be Relied Upon Company Delays Release of Third Quarter Financial Results Waltham, Massachusetts – October 25, 2024 – Evolv Technology (“Evolv” or the “Company”) (NASDAQ: EVLV), a leadi |
|
| August 8, 2024 |
Evolv Technology Reports Second Quarter Financial Results Exhibit 99.1 Investor Relations: Brian Norris Senior Vice President of Finance and Investor Relations [email protected] Evolv Technology Reports Second Quarter Financial Results •Q2 Revenue of $25.5 million, up 29% year-over-year •Q2 Ending ARR1 of $88.9 million, up 64% year-over-year •Q2 Ending RPO2 of $262.9 million, up 33% year-over-year •Q2 Ending Evolv Express® subscriptions of 5,32 |
|
| August 8, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 00 |
|
| August 8, 2024 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 8, 2024 Evolv Technologies Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39417 84-4473840 (State or other jurisdiction of incorporation) (C |
|
| June 4, 2024 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 31, 2024 Evolv Technologies Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39417 84-4473840 (State or other jurisdiction of incorporation) (Com |
|
| May 31, 2024 |
Exhibit 1.01 to Form SD Evolv Technologies Holdings, Inc. Conflict Minerals Report For the Reporting Period January 1, 2023 to December 31, 2023 This Conflict Minerals Report (“CMR”) has been prepared by Evolv Technologies Holdings, Inc. (herein referred to, alternatively, as “Evolv,” “we” and “our”). This CMR for the reporting period January 1, 2023 to December 31, 2023 has been prepared in accor |
|
| May 31, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD SPECIALIZED DISCLOSURE REPORT EVOLV TECHNOLOGIES HOLDINGS, INC. (Exact name of registrant as specified in its charter) Delaware 001-39417 (State or other jurisdiction of incorporation) (Commission file number) 500 Totten Pond Road, 4th Floor Waltham, Massachusetts 02451 (Address of principal executive offices) (Zip cod |
|
| May 9, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 0 |
|
| May 9, 2024 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 9, 2024 Evolv Technologies Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39417 84-4473840 (State or other jurisdiction of incorporation) (Comm |
|
| May 9, 2024 |
Evolv Technology Reports First Quarter Financial Results Exhibit 99.1 Investor Relations: Brian Norris Senior Vice President of Finance and Investor Relations [email protected] Evolv Technology Reports First Quarter Financial Results •Q1 Revenue of $21.7 million, up 17% year-over-year •Q1 Ending ARR1 of $82.5 million, up 96% year-over-year •Q1 Ending RPO2 of $254.1 million, up 57% year-over-year •Q1 Ending Evolv Express® subscriptions of 4,882 |
|
| April 15, 2024 |
TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. |
|
| April 15, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. |
|
| April 5, 2024 |
TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. |
|
| February 29, 2024 |
Evolv Technology Reports Record Fourth Quarter and Full Year Financial Results Exhibit 99.1 Investor Relations: Brian Norris Senior Vice President of Finance and Investor Relations [email protected] Evolv Technology Reports Record Fourth Quarter and Full Year Financial Results •Q4 Revenue of $21.8 million, up 4% year-over-year •Q4 Ending ARR1 of $75.0 million, up 120% year-over-year •Q4 Ending RPO2 of $240.5 million, up 66% year-over-year •Q4 Ending Evolv Express® |
|
| February 29, 2024 |
Policy for Recovery of Erroneously Awarded Compensation Exhibit 97 EVOLV TECHNOLOGIES HOLDINGS, INC. POLICY FOR RECOVERY OF ERRONEOUSLY AWARDED COMPENSATION Evolv Technologies Holdings, Inc. (the “Company”) has adopted this Policy for Recovery of Erroneously Awarded Compensation (the “Policy”), effective as of October 2, 2023 (the “Effective Date”). Capitalized terms used in this Policy but not otherwise defined herein are defined in Section 11. 1.Pers |
|
| February 29, 2024 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 29, 2024 Evolv Technologies Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39417 84-4473840 (State or other jurisdiction of incorporation) |
|
| February 29, 2024 |
Exhibit 21.1 LIST OF SUBSIDIARIES The following is a list of the direct and indirect subsidiaries of Evolv Technologies Holdings, Inc., that is current as of December 31, 2023: Subsidiaries Jurisdiction Evolv Technologies, Inc. United States Evolv Technology UK Ltd. United Kingdom Give Evolv LLC United States |
|
| February 29, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-39417 EVOLV TECHNOLOGIES HOLDIN |
|
| February 20, 2024 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 19, 2024 Evolv Technologies Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39417 84-4473840 (State or other jurisdiction of incorporation) |
|
| February 20, 2024 |
Evolv Technology Provides Regulatory Update Exhibit 99.1 Investor Relations: Brian Norris Senior Vice President of Finance and Investor Relations [email protected] Evolv Technology Provides Regulatory Update Waltham, Massachusetts – February 19, 2024 – Evolv Technology (NASDAQ: EVLV), the leading security technology company pioneering AI-based weapons detection to create safer experiences, today provided an update on a request rec |
|
| February 14, 2024 |
SC 13G/A 1 d787788dsc13ga.htm SC 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2 Under the Securities Exchange Act of 1934 (Amendment No. 1)* Evolv Technologies Holdings, Inc. (Name of Issuer) Class A Common Stock, p |
|
| February 14, 2024 |
EX-99.1 2 d787788dex991.htm EX-99.1 Exhibit 99.1 Joint Filing Agreement Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13G need be filed with respect to the ownership by each of the undersigned of shares of Evolv Technologies Holdings, Inc. EXECUTED this 14th day of Februar |
|
| February 14, 2024 |
EX-99.2 3 d787788dex992.htm EX-99.2 Exhibit 2 Members of the Group General Catalyst Group V, L.P. GC Entrepreneurs Fund V, L.P. |
|
| February 14, 2024 |
EVLV / Evolv Technologies Holdings, Inc. / Lux Venture Partners III, LLC Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 2)* EVOLV TECHNOLOGIES HOLDINGS, INC. (Name of Issuer) Class A Common Stock, par value $0.0001 per share (Title of Class of Securities) 30049H102 (CUSIP Number) Peter Hebert Lux Capital Management, LLC 920 Broadway, 11th Floor New York, NY 10010 (646) 475-43 |
|
| January 31, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 29, 2024 Evolv Technologies Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39417 84-4473840 (State or other jurisdiction of incorporation) |
|
| January 31, 2024 |
Amended and Restated Bylaws of Evolv Technologies Holdings, Inc. (a Delaware corporation) as of January 29, 2024 Table of Contents Page Article I - Corporate Offices 1.1 Registered Office 1 1.2 Other Offices 1 Article II - Meetings of Stockholders 1 2.1 Place of Meetings 1 2.2 Annual Meeting 1 2.3 Special Meeting 1 2.4 Notice of Business to be Brought before a Meeting 2 2.5 Notice of Nominations f |
|
| November 17, 2023 |
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13D (RULE 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(a) (Amendment No. 1)* Evolv Technologies Holdings, Inc. (Name of Issuer) Class A Common Stock, $0.0001 par value per share (Title of Class of Securities) 30049H102 (CUSIP Number) Spencer Pu |
|
| November 9, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file numbe |
|
| November 9, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A (Amendment No.1) Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A (Amendment No.1) (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commiss |
|
| November 9, 2023 |
Exhibit 99.1 Investor Relations: Brian Norris Senior Vice President of Finance and Investor Relations [email protected] Evolv Technology Reports Record Third Quarter Financial Results – Company Reaffirms Previously Raised Outlook for 2023 and Issues Outlook for 2024 Above Street Consensus – •Q3 Revenue of $20.2 million, up 22% year-over-year •Q3 Ending ARR1 of $65.8 million, up 129% year |
|
| November 9, 2023 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 9, 2023 Evolv Technologies Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39417 84-4473840 (State or other jurisdiction of incorporation) |
|
| November 9, 2023 |
Amended Non-Employee Director Compensation Policy EVOLV TECHNOLOGIES HOLDINGS, INC. NON-EMPLOYEE DIRECTOR COMPENSATION POLICY (Revised as of July 19, 2023) Non-employee members of the board of directors (the “Board”) of Evolv Technologies Holdings, Inc. (the “Company”) shall be eligible to receive cash and equity compensation as set forth in this Non-Employee Director Compensation Policy (this “Policy”). The cash and equity compensation described |
|
| November 6, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 31, 2023 Evolv Technologies Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39417 84-4473840 (State or other jurisdiction of incorporation) |
|
| October 25, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 23, 2023 Evolv Technologies Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39417 84-4473840 (State or other jurisdiction of incorporation) |
|
| October 12, 2023 |
Exhibit 99.1 Investor Relations: Brian Norris Senior Vice President of Finance and Investor Relations [email protected] Evolv Technology Announces Preliminary Results for Third Quarter 2023 – Company Raises Outlook for 2023 – Waltham, Massachusetts – October 12, 2023 – Evolv Technology (NASDAQ: EVLV), the leader in AI-based weapons detection security screening, today announced preliminar |
|
| October 12, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 12, 2023 Evolv Technologies Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39417 84-4473840 (State or other jurisdiction of incorporation) |
|
| August 10, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 10, 2023 Evolv Technologies Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39417 84-4473840 (State or other jurisdiction of incorporation) ( |
|
| August 10, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 00 |
|
| August 10, 2023 |
Evolv Technology Reports Record Second Quarter Financial Results – Company Raises Outlook for 2023 – Exhibit 99.1 Investor Relations: Brian Norris Senior Vice President of Finance and Investor Relations [email protected] Evolv Technology Reports Record Second Quarter Financial Results – Company Raises Outlook for 2023 – •Q2 Revenue of $19.8 million, up 119% year-over-year •Q2 Ending ARR1 of $54.3 million, up 160% year-over-year •Q2 Ending RPO2 of $198.3 million, up 145% year-over-year • |
|
| June 2, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 30, 2023 Evolv Technologies Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39417 84-4473840 (State or other jurisdiction of incorporation) (Com |
|
| May 10, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 10, 2023 Evolv Technologies Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39417 84-4473840 (State or other jurisdiction of incorporation) (Com |
|
| May 10, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 0 |
|
| May 10, 2023 |
Evolv Technology Reports Record First Quarter Financial Results – Company Raises Outlook for 2023 – Exhibit 99.1 Investor Relations: Brian Norris Senior Vice President of Finance and Investor Relations [email protected] Evolv Technology Reports Record First Quarter Financial Results – Company Raises Outlook for 2023 – •Q1 Revenue of $18.6 million, up 113% year-over-year •Q1 Ending ARR1 of $42.0 million, up 153% year-over-year •Q1 Ending RPO2 of $161.8 million, up 154% year-over-year •Q |
|
| April 13, 2023 |
TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. |
|
| April 13, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. |
|
| April 3, 2023 |
IT IS HEREBY ORDERED this day of , 2023, that: IN THE COURT OF CHANCERY OF THE STATE OF DELAWARE IN RE EVOLV TECHNOLOGIES HOLDINGS, INC. |
|
| April 3, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 28, 2023 Evolv Technologies Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39417 84-4473840 (State or other jurisdiction of incorporation) (C |
|
| March 24, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-39417 EVOLV TECHNOLOGIES HOLDIN |
|
| March 24, 2023 |
Exhibit 10.9 AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT THIS AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of July 16, 2021, is made and entered into by and among Evolv Technologies Holdings, Inc., a Delaware corporation (“Evolv”), NewHold Investment Corp., a Delaware corporation (the “Company”), NewHold Industrial Technology Holdings LLC, a Delaware limit |
|
| March 24, 2023 |
Exhibit 21.1 LIST OF SUBSIDIARIES The following is a list of the direct and indirect subsidiaries of Evolv Technologies Holdings, Inc., that is current as of December 31, 2022: Subsidiaries Jurisdiction Evolv Technologies, Inc. United States Evolv Technology UK Ltd. United Kingdom Give Evolv LLC United States |
|
| March 17, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 15, 2023 Evolv Technologies Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39417 84-4473840 (State or other jurisdiction of incorporation) (C |
|
| March 17, 2023 |
IN THE COURT OF CHANCERY OF THE STATE OF DELAWARE Exhibit 99.1 IN THE COURT OF CHANCERY OF THE STATE OF DELAWARE IN RE EVOLV TECHNOLOGIES HOLDINGS, INC. ) C.A. No. 2023- - ) VERIFIED PETITION FOR RELIEF PURSUANT TO 8 DEL. C. § 205 Petitioner Evolv Technologies Holdings, Inc. (“Evolv” or the “Company”), by and through its undersigned counsel, brings this petition pursuant to 8 Del. C. § 205, seeking to have this Court validate a corporate act as f |
|
| March 2, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 24, 2023 Evolv Technologies Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39417 84-4473840 (State or other jurisdiction of incorporation) |
|
| March 2, 2023 |
Evolv Technologies Holdings, Inc. Executive Officer Performance Bonus Plan Evolv Technologies Holdings, INC. Executive Officer Performance Bonus Plan 1.Purpose The Evolv Technologies Holdings, Inc. Executive Officer Performance Bonus Plan (the “Plan”) is adopted under the Evolv Technologies Holdings, Inc. 2021 Incentive Award Plan (as amended, the “Incentive Plan”) and designed to motivate and inspire participating employees to make important contributions to the success |
|
| March 1, 2023 |
Evolv Technology Reports Record Fourth Quarter and Full Year Financial Results Exhibit 99.1 Investor Relations: Brian Norris Vice President of Finance and Investor Relations [email protected] Evolv Technology Reports Record Fourth Quarter and Full Year Financial Results •Q4 Revenue of $20.9 million, up 217% year-over-year •Q4 Ending ARR1 of $34.1 million, up 164% year-over-year •Q4 Ending RPO2 of $144.6 million, up 181% year-over-year •Q4 Ending Evolv Express® subs |
|
| March 1, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 1, 2023 Evolv Technologies Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39417 84-4473840 (State or other jurisdiction of incorporation) (Co |
|
| February 13, 2023 |
EVLV / Evolv Technologies Holdings, Inc. Class A / Gates Ventures, Llc - SC 13G/A Passive Investment SC 13G/A 1 tm236465d1sc13ga.htm SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* Evolv Technologies Holdings, Inc. (Name of Issuer) Class A common stock, par value $0.0001 per share (Title of Class of Securities) 30049H102 (CUSIP Number) December 31, 2022 (Date of Event Which Requires Filing o |
|
| January 30, 2023 |
EX-99.1 2 evolv-exhibt1to13dellenbog.htm EX-99.1 Sales Plan Sales Plan, adopted (the "Sales Plan", and such date the "Adoption Date”), between (“Seller”) and J.P. Morgan Securities LLC (“JPMS”). The purpose of this Sales Plan is to achieve the investment objectives of broader diversification of investments, while reducing the risk of over concentration in a particular investment. RECITALS WHEREAS, |
|
| January 30, 2023 |
EVLV / Evolv Technologies Holdings, Inc. Class A / Ellenbogen Michael - SC 13D Activist Investment |
|
| December 21, 2022 |
Exhibit 10.1 LOAN AND SECURITY AGREEMENT THIS LOAN AND SECURITY AGREEMENT (this ?Agreement?) is dated as of the Effective Date between SILICON VALLEY BANK, a California corporation (?Bank?), and the borrowers listed on Schedule I hereto (?Borrower?). The parties agree as follows: 1 LOAN AND TERMS OF PAYMENT 1.1 Hardware Advances. (a) Availability. Subject to the terms and conditions of this Agreem |
|
| December 21, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 21, 2022 Evolv Technologies Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39417 84-4473840 (State or other jurisdiction of incorporation) |
|
| December 21, 2022 |
Exhibit 99.1 Investor Relations: Brian Norris Vice President of Finance and Investor Relations [email protected] Evolv Technology Announces $75 Million in Non-Dilutive Debt Financing with Silicon Valley Bank ? Facility Expected to Support Company?s Rapidly Growing Subscription Offering ? Waltham, Massachusetts ? December 21, 2022 ? Evolv Technology (NASDAQ: EVLV), the leader in AI-based |
|
| November 9, 2022 |
Evolv Technology Reports Record Third Quarter Financial Results – Company Raises Outlook for 2022 – Exhibit 99.1 Investor Relations: Brian Norris Vice President of Finance and Investor Relations [email protected] Evolv Technology Reports Record Third Quarter Financial Results ? Company Raises Outlook for 2022 ? ?Q3 Revenue of $16.5 million, up 96% year-over-year ?Q3 Ending ARR of $28.7 million, up 189% year-over-year ?Q3 Ending RPO of $109.4 million, up 220% year-over-year ?Q3 Ending E |
|
| November 9, 2022 |
Form of Option Award Agreement under the 2021 Incentive Award Plan EVOLV TECHNOLOGIES HOLDINGS, INC. 2021 INCENTIVE AWARD PLAN STOCK OPTION GRANT NOTICE Capitalized terms not specifically defined in this Stock Option Grant Notice (the ?Grant Notice?) have the meanings given to them in the Evolv Technologies Holdings, Inc. 2021 Incentive Award Plan (as amended from time to time, the ?Plan?). Evolv Technologies Holdings, Inc. (the ?Company?) hereby grants to the pa |
|
| November 9, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 9, 2022 Evolv Technologies Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39417 84-4473840 (State or other jurisdiction of incorporation) |
|
| November 9, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file numbe |
|
| October 31, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 25, 2022 Evolv Technologies Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39417 84-4473840 (State or other jurisdiction of incorporation) |
|
| October 31, 2022 |
Evolv Technologies Holdings, Inc. Severance and Change in Control Plan Exhibit 10.1 Evolv Technologies Holdings, Inc. Severance And Change In Control Plan Section 1. Introduction and Purpose. The purpose of this Executive Severance and Change in Control Plan (the “Plan”) is to enable Evolv Technologies Holdings, Inc. (the “Company”) to offer certain protections to certain senior-level employees if their employment with the Company, is terminated without Cause or for |
|
| October 27, 2022 |
As filed with the Securities and Exchange Commission on October 27, 2022 TABLE OF CONTENTS As filed with the Securities and Exchange Commission on October 27, 2022 Registration No. |
|
| September 21, 2022 |
September 21, 2022 Via EDGAR Securities and Exchange Commission Division of Corporation Finance Office of Technology 100 F. |
|
| September 7, 2022 |
Filed pursuant to Rule 424(b)(3) Registration Statement No. 333-258748 Prospectus Supplement No. 7 (To Prospectus dated April 27, 2022) This prospectus supplement updates, amends and supplements the prospectus dated April 27, 2022 (the ?Prospectus?), which forms a part of our Registration Statement on Form S-1 (Registration No. 333-258748). Capitalized terms used in this prospectus supplement and |
|
| September 7, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): September 2, 2022 Evolv Technologies Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39417 84-4473840 (State or other jurisdiction of incorporation) |
|
| September 6, 2022 |
EVLV / Evolv Technologies Holdings, Inc. Class A / Lux Venture Partners III, LLC Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 1)* EVOLV TECHNOLOGIES HOLDINGS, INC. (Name of Issuer) Class A Common Stock, par value $0.0001 per share (Title of Class of Securities) 30049H102 (CUSIP Number) Peter Hebert Lux Capital Management, LLC 920 Broadway, 11th Floor New York, NY 10010 (646) 475-43 |
|
| August 18, 2022 |
Table of Contents Filed pursuant to Rule 424(b)(3) Registration Statement No. 333-258748 Prospectus Supplement No. 6 (To Prospectus dated April 27, 2022) This prospectus supplement updates, amends and supplements the prospectus dated April 27, 2022 (the ?Prospectus?), which forms a part of our Registration Statement on Form S-1 (Registration No. 333-258748). Capitalized terms used in this prospect |
|
| August 18, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 00 |
|
| August 16, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): ? Form 10-K ? Form 20-F ? Form 11-K ? Form 10-Q ? Form 10-D ? Form N-CEN ? Form N-CSR For Period Ended: June 30, 2022 ? Transition Report on Form 10-K ? Transition Report on Form 20-F ? Transition Report on Form 11-K ? Transition Report on Form 10-Q For the Transition Period |
|
| August 10, 2022 |
Exhibit 99.1 Investor Relations: Brian Norris Vice President of Finance and Investor Relations [email protected] Evolv Technology Reports Strong Second Quarter Financial Results ? Company Reaffirms Outlook for 2022 ? ?Q2 Revenue of $9.1 million, up 94% year-over-year ?Q2 Ending ARR of $20.9 million, up 181% year-over-year ?Q2 Ending RPO of $66.2 million, up 166% year-over-year ?Q2 Ending |
|
| August 10, 2022 |
Filed pursuant to Rule 424(b)(3) Registration Statement No. 333-258748 Prospectus Supplement No. 5 (To Prospectus dated April 27, 2022) This prospectus supplement updates, amends and supplements the prospectus dated April 27, 2022 (the ?Prospectus?), which forms a part of our Registration Statement on Form S-1 (Registration No. 333-258748). Capitalized terms used in this prospectus supplement and |
|
| August 10, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 10, 2022 Evolv Technologies Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39417 84-4473840 (State or other jurisdiction of incorporation) ( |
|
| May 27, 2022 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 26, 2022 Evolv Technologies Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39417 84-4473840 (State or other jurisdiction of incorporation) (Com |
|
| May 27, 2022 |
Filed pursuant to Rule 424(b)(3) Registration Statement No. 333-258748 Prospectus Supplement No. 4 (To Prospectus dated April 27, 2022) This prospectus supplement updates, amends and supplements the prospectus dated April 27, 2022 (the ?Prospectus?), which forms a part of our Registration Statement on Form S-1 (Registration No. 333-258748). Capitalized terms used in this prospectus supplement and |
|
| May 19, 2022 |
Filed pursuant to Rule 424(b)(3) Registration Statement No. 333-258748 Prospectus Supplement No. 3 (To Prospectus dated April 27, 2022) This prospectus supplement updates, amends and supplements the prospectus dated April 27, 2022 (the ?Prospectus?), which forms a part of our Registration Statement on Form S-1 (Registration No. 333-258748). Capitalized terms used in this prospectus supplement and |
|
| May 19, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 13, 2022 Evolv Technologies Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39417 84-4473840 (State or other jurisdiction of incorporation) (Com |
|
| May 19, 2022 |
Executive Employment Agreement, between Evolv Technologies, Inc. and Mark Donohue Exhibit 10.1 EXECUTIVE EMPLOYMENT AGREEMENT This Executive Employment Agreement (the "Agreement"), made and entered as of May 18, 2022 (the "Effective Date"), by and between Evolv Technologies Holdings, Inc. ("Company"), and Mark Donohue ("Executive") (each a "Party," and collectively the "Parties"). WHEREAS, Company wishes to employ Executive as an employee of Company and the Executive wishes to |
|
| May 19, 2022 |
Exhibit 99.1 Investor Relations: Brian Norris Vice President of Investor Relations [email protected] Evolv Technology Appoints New Chief Financial Officer – Former CFO Transitioning to Pursue CEO Role – – Company Welcomes Proven Finance Executive with Background in High-Growth SaaS, Cybersecurity and Networking – – Mark Donohue to join from Vestmark, Rapid7, Cisco and Starent Networks – |
|
| May 16, 2022 |
Table of Contents ? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. |
|
| May 16, 2022 |
Table of Contents Filed pursuant to Rule 424(b)(3) Registration Statement No. 333-258748 Prospectus Supplement No. 2 (To Prospectus dated April 27, 2022) This prospectus supplement updates, amends and supplements the prospectus dated April 27, 2022 (the ?Prospectus?), which forms a part of our Registration Statement on Form S 1 (Registration No. 333 258748). Capitalized terms used in this prospect |
|
| May 13, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q Table of Contents ? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. |
|
| May 11, 2022 |
Filed pursuant to Rule 424(b)(3) Registration Statement No. 333-258748 Prospectus Supplement No. 1 (To Prospectus dated April 27, 2022) This prospectus supplement updates, amends and supplements the prospectus dated April 27, 2022 (the ?Prospectus?), which forms a part of our Registration Statement on Form S-1 (Registration No. 333-258748). Capitalized terms used in this prospectus supplement and |
|
| May 11, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 11, 2022 Evolv Technologies Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39417 84-4473840 (State or other jurisdiction of incorporation) (Com |
|
| May 11, 2022 |
Exhibit 99.1 Investor Relations: Brian Norris Vice President of Investor Relations [email protected] Evolv Technology Reports Strong First Quarter Financial Results ? Company Reaffirms Outlook for 2022 ? ? Q1 Revenue of $8.7 million, up 118% year-over-year ? Q1 Ending ARR of $16.6 million, up 207% year-over-year ? Q1 Ending Evolv Express? subscriptions of 910, up 227% year-over-year Walt |
|
| April 29, 2022 |
TABLE OF CONTENTS ?Filed Pursuant to Rule 424(b)(3)? ?Registration No. 333-258748? Evolv Technologies Holdings, Inc. 158,574,790 Shares of Class A Common Stock 5,700,000 Warrants to Purchase Shares of Class A Common Stock 14,325,000 Shares of Class A Common Stock Underlying Warrants ? This prospectus relates to the offer and sale from time to time by the selling securityholders named in this prosp |
|
| April 18, 2022 |
As filed with the Securities and Exchange Commission on April 18, 2022 Table of Contents As filed with the Securities and Exchange Commission on April 18, 2022 Registration No. |
|
| April 14, 2022 |
Filed pursuant to Rule 424(b)(3) Registration Statement No. 333-258748 Prospectus Supplement No. 7 (To Prospectus dated September 3, 2021) This prospectus supplement updates, amends and supplements the prospectus dated September 3, 2021 (the ?Prospectus?), which forms a part of our Registration Statement on Form S-1 (Registration No. 333-258748). Capitalized terms used in this prospectus supplemen |
|
| April 14, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): April 8, 2022 Evolv Technologies Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39417 84-4473840 (State or other jurisdiction of incorporation) (Co |
|
| April 13, 2022 |
TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549? SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. |
|
| April 13, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. |
|
| March 31, 2022 |
Exhibit 99.1 Evolv Technology Awarded U.S. Department of Homeland Security (DHS) SAFETY Act Designation for Evolv Express? This distinction qualifies Evolv Technology to receive the SAFETY Act?s benefits for selected Anti-Terrorism Technologies WALTHAM, Mass. ? March 31, 2022 ? Evolv Technology (NASDAQ: EVLV, ?Evolv?), the global leader in weapons detection security screening, today announced that |
|
| March 31, 2022 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 31, 2022 Evolv Technologies Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39417 84-4473840 (State or other jurisdiction of incorporation) (C |
|
| March 28, 2022 |
Table of Contents Filed pursuant to Rule 424(b)(3) Registration Statement No. 333-258748 ? Prospectus Supplement No. 6 (To Prospectus dated September 3, 2021) ? This prospectus supplement updates, amends and supplements the prospectus dated September 3, 2021 (the ?Prospectus?), which forms a part of our Registration Statement on Form S-1 (Registration No. 333-258748). Capitalized terms used in thi |
|
| March 28, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K Table of Contents ? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. |
|
| March 28, 2022 |
Description of registered securities Exhibit 4.4 DESCRIPTION OF THE REGISTRANT?S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED General As of December 31, 2021, Evolv Technologies Holdings, Inc. had two classes of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended (the ?Exchange Act?). References herein to the ?Company,? ?Evolv,? ?we,? ?us,? and ? |
|
| March 28, 2022 |
As filed with the Securities and Exchange Commission on March 28, 2022 POS EX 1 tm229687d1posex.htm POS EX As filed with the Securities and Exchange Commission on March 28, 2022 Registration No. 333-258748 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Post-Effective Amendment No. 1 to FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Evolv Technologies Holdings, Inc. (Exact name of registrant as specified in its charter) Delaw |
|
| March 28, 2022 |
? Exhibit 10.10 ? EXECUTION VERSION ? FIRST AMENDMENT TO AGREEMENT AND PLAN OF MERGER ? THIS FIRST AMENDMENT TO AGREEMENT AND PLAN OF MERGER (this ?Amendment?) is made as of June 5, 2021 (the ?Amendment Date?) by and among NewHold Investment Corp., a Delaware corporation (?Parent?), NHIC Sub Inc., a Delaware limited liability company and wholly-owned subsidiary of Parent (?Merger Sub?), and Evolv |
|
| March 28, 2022 |
Exhibit 21.1 ? LIST OF SUBSIDIARIES ? The following is a list of the direct and indirect subsidiaries of Evolv Technologies Holdings, Inc., that is current as of December 31, 2021: ? ? ? Subsidiaries Jurisdiction Evolv Technologies, Inc. United States Evolv Technology UK Ltd. United Kingdom Give Evolv LLC United States ? |
|
| March 14, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 14, 2022 Evolv Technologies Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39417 84-4473840 (State or other jurisdiction of incorporation) (C |
|
| March 14, 2022 |
Exhibit 99.1 Investor Relations: Brian Norris Vice President of Investor Relations [email protected] Public Relations: Fitz Barth Director of Communications [email protected] Evolv Technology Reports Strong Fourth Quarter and Full Year Financial Results ? Company Issues Outlook for 2022 ? ? Q4 Total Contract Value (?TCV?)1 of $17.9 million, up 201% year-over-year ? Q4 Revenue of |
|
| March 14, 2022 |
©Copyright 2022 Evolv Technologies, Inc. All Rights Reserved. Q4 2021 Earnings Call March 14, 2022 Exhibit 99.2 ?Copyright 2022 Evolv Technologies, Inc. All Rights Reserved. Q4 2021 Earnings Call March 14, 2022 ?Copyright 2022 Evolv Technologies, Inc. All Rights Reserved. Safe Harbor Statement & Use of Non - GAAP Measures 2 Certain statements in this press release may constitute ?forward - looking? statements and information, within the meaning of Sect ion 27A of the Securities Act of 1933, Sec |
|
| March 14, 2022 |
Filed pursuant to Rule 424(b)(3) Registration Statement No. 333-258748 Prospectus Supplement No. 5 (To Prospectus dated September 3, 2021) This prospectus supplement updates, amends and supplements the prospectus dated September 3, 2021 (the ?Prospectus?), which forms a part of our Registration Statement on Form S-1 (Registration No. 333-258748). Capitalized terms used in this prospectus supplemen |
|
| February 25, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 25, 2022 Evolv Technologies Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39417 84-4473840 (State or other jurisdiction of incorporation) |
|
| February 15, 2022 |
EX-99.1 CUSIP No. 30049H102 13G Page 19 of 21 Exhibit 1 Joint Filing Agreement Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13G need be filed with respect to the ownership by each of the undersigned of shares of Evolv Technologies Holdings, Inc. EXECUTED this 14th day of |
|
| February 15, 2022 |
EX-99.2 CUSIP No. 30049H102 13G Page 21 of 21 Exhibit 2 Members of the Group General Catalyst Group V, L.P. GC Entrepreneurs Fund V, L.P. |
|
| February 15, 2022 |
SC 13G SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2 Under the Securities Exchange Act of 1934 (Amendment No. )* Evolv Technologies Holdings, Inc. (Name of Issuer) Class A Common Stock, par value $0.0001 per share (Title |
|
| February 14, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* Evolv Technologies Holdings Inc (Name of Issuer) Class A common stock, par value $0.0001 per share (Title of Class of Securities) 30049H102 (CUSIP Number) December 31, 2021 (Date of Event which Requires Filing of this Statement) Check the appropriate box |
|
| February 14, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* Evolv Technologies Holdings, Inc.** (Name of Issuer) Class A Common Stock, par value $0.0001 per share (Title of Class of Securities) 30049H102 (CUSIP Number) December 31, 2021 (Date of Event which Requires Filing of this Statement) Check the appropriate |
|
| February 14, 2022 |
EVLV / Evolv Technologies Holdings, Inc. Class A / UBS OCONNOR LLC - SC 13G/A Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* Evolv Technologies Holdings, Inc. (Name of Issuer) Class A common stock, par value $0.0001 per share (Title of Class of Securities) 30049H102** (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriate |
|
| February 4, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 31, 2022 Evolv Technologies Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39417 84-4473840 (State or other jurisdiction of incorporation) |
|
| February 4, 2022 |
Filed pursuant to Rule 424(b)(3) Registration Statement No. 333-258748 Prospectus Supplement No. 4 (To Prospectus dated September 3, 2021) This prospectus supplement updates, amends and supplements the prospectus dated September 3, 2021 (the “Prospectus”), which forms a part of our Registration Statement on Form S-1 (Registration No. 333-258748). Capitalized terms used in this prospectus supplemen |
|
| January 28, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 28, 2022 Evolv Technologies Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39417 84-4473840 (State or other jurisdiction of incorporation) |
|
| January 28, 2022 |
Evolv Technologies Holdings, Inc. Filed pursuant to Rule 424(b)(3) Registration Statement No. 333-258748 Prospectus Supplement No. 3 (To Prospectus dated September 3, 2021) Evolv Technologies Holdings, Inc. This prospectus supplement updates, amends and supplements the prospectus dated September 3, 2021 (the ?Prospectus?), which forms a part of our Registration Statement on Form S-1 (Registration No. 333-258748). Capitalized terms |
|
| January 7, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* Evolv Technologies Holdings, Inc. (Name of Issuer) Common Stock, par value $0.0001 (Title of Class of Securities) 30049H102 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate th |
|
| November 15, 2021 |
Evolv Technologies Holdings, Inc. Filed pursuant to Rule 424(b)(3) Registration Statement No. 333-258748 Prospectus Supplement No. 2 (To Prospectus dated September 3, 2021) Evolv Technologies Holdings, Inc. This prospectus supplement updates, amends and supplements the prospectus dated September 3, 2021 (the “Prospectus”), which forms a part of our Registration Statement on Form S-1 (Registration No. 333-258748). Capitalized terms |
|
| November 15, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents ? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| November 15, 2021 |
Form of Restricted Stock Unit Award Agreement under the 2021 Incentive Award Plan Exhibit 10.1 EVOLV TECHNOLOGIES HOLDINGS, INC. 2021 INCENTIVE AWARD PLAN RESTRICTED STOCK UNIT GRANT NOTICE Capitalized terms not specifically defined in this Restricted Stock Unit Grant Notice (the ?Grant Notice?) have the meanings given to them in the Evolv Technologies Holdings, Inc. 2021 Incentive Award Plan (as amended from time to time, the ?Plan?). Evolv Technologies Holdings, Inc. (the ?Co |
|
| November 15, 2021 |
Second Amended and Restated Certificate of Incorporation. ? Exhibit 3.1 ? Delaware The First State ? I, JEFFREY W. BULLOCK, SECRETARY OF STATE OF THE STATE OF DELAWARE, DO HEREBY CERTIFY THE ATTACHED IS A TRUE AND CORRECT COPY OF THE RESTATED CERTIFICATE OF "NEWHOLD INVESTMENT CORP.", CHANGING ITS NAME FROM "NEWHOLD INVESTMENT CORP." TO "EVOLV TECHNOLOGIES HOLDINGS, INC.", FILED IN THIS OFFICE ON THE SIXTEENTH DAY OF JULY, A.D. 2021, AT 11:29 O'CLOCK A.M |
|
| November 10, 2021 |
Evolv Technology Reports Strong Third Quarter Financial Results – Company Raises Outlook for 2021 – Exhibit 99.1 Investor Relations: Public Relations: Brian Norris Fitz Barth Vice President of Investor Relations Director of Communications [email protected] [email protected] ? Evolv Technology Reports Strong Third Quarter Financial Results ? Company Raises Outlook for 2021 ? ? Q3 Total Contract Value (TCV) of $16.9 million, up 365% year-over-year ? Q3 Revenue of $8.4 million, u |
|
| November 10, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition ? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 10, 2021 Evolv Technologies Holdings, Inc. (Exact name of registrant as specified in its charter) ? ? ? ? ? Delaware ? 001-39417 ? 84-4473840 (State or other jurisdiction |
|
| November 1, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 29, 2021 Evolv Technologies Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39417 84-4473840 (State or other jurisdiction of incorporation) |
|
| November 1, 2021 |
Exhibit 99.1 Investor Relations: Brian Norris Vice President of Investor Relations [email protected] Evolv Technology Appoints Mario Ramos as Chief Financial Officer ? Company Welcomes Experienced Fortune 5 Executive to Support Growth Plans ? Waltham, Massachusetts ? November 1, 2021 ? Evolv Technology (NASDAQ: EVLV), the global leader in weapons detection security screening, today annou |
|
| November 1, 2021 |
Executive Employment Agreement, between Evolv Technologies, Inc. and Mario Ramos Exhibit 10.1 EXECUTIVE EMPLOYMENT AGREEMENT This Executive Employment Agreement (the ?Agreement?), is made and entered into as of October 29, 2021 (the ?Effective Date?), by and between Evolv Technologies Holdings, Inc. (?Company?), and Mario Ramos (?Executive?) (each a ?Party,? and collectively the ?Parties?). WHEREAS, Company wishes to employ Executive as an employee of Company and the Executive |
|
| November 1, 2021 |
Evolv Technologies Holdings, Inc. Filed pursuant to Rule 424(b)(3) Registration Statement No. 333-258748 Prospectus Supplement No. 1 (To Prospectus dated September 3, 2021) Evolv Technologies Holdings, Inc. This prospectus supplement updates, amends and supplements the prospectus dated September 3, 2021 (the ?Prospectus?), which forms a part of our Registration Statement on Form S-1 (Registration No. 333-258748). Capitalized terms |
|
| September 21, 2021 |
Evolv Technologies, Inc. 2013 Employee, Director and Consultant Equity Incentive Plan. Exhibit 99.3 EVOLV TECHNOLOGIES, INC. 2013 EMPLOYEE, DIRECTOR AND CONSULTANT EQUITY INCENTIVE PLAN 1. DEFINITIONS. Unless otherwise specified or unless the context otherwise requires, the following terms, as used in this Evolv Technologies, Inc. 2013 Employee, Director and Consultant Equity Incentive Plan, have the following meanings: Administrator means the Board of Directors, unless it has deleg |
|
| September 21, 2021 |
Evolv Technologies Holdings, Inc. 2021 Employee Stock Purchase Plan. Exhibit 99.2 EVOLV TECHNOLOGIES HOLDINGS, INC. 2021 EMPLOYEE STOCK PURCHASE PLAN Article I. PURPOSE The purposes of this Evolv Technologies Holdings, Inc. 2021 Employee Stock Purchase Plan (as it may be amended or restated from time to time, the ?Plan?) are to assist Eligible Employees of Evolv Technologies Holdings, Inc. 2021, a Delaware corporation (the ?Company?), and its Designated Subsidiarie |
|
| September 21, 2021 |
Evolv Technologies Holdings, Inc. 2021 Incentive Award Plan. Exhibit 99.1 EVOLV TECHNOLOGIES HOLDINGS, INC. 2021 INCENTIVE AWARD PLAN ARTICLE 1. PURPOSE The purpose of the Evolv Technologies Holdings, Inc. 2021 Incentive Award Plan (as it may be amended or restated from time to time, the ?Plan?) is to promote the success and enhance the value of Evolv Technologies Holdings, Inc., a Delaware corporation (the ?Company?) by linking the individual interests of |
|
| September 21, 2021 |
As filed with the Securities and Exchange Commission on September 21, 2021 ?As filed with the Securities and Exchange Commission on September 21, 2021 ? Registration No. |
|
| September 9, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): September 9, 2021 Evolv Technologies Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39417 84-4473840 (State or other jurisdiction of incorporation) |
|
| September 3, 2021 |
TABLE OF CONTENTS ?Filed Pursuant to Rule 424(b)(3)? ?Registration No. 333-258748? P R O S P E C T U S Evolv Technologies Holdings, Inc. 158,574,790 Shares of Class A Common Stock 5,700,000 Warrants to Purchase Shares of Class A Common Stock 14,325,000 Shares of Class A Common Stock Underlying Warrants ? This prospectus relates to the offer and sale from time to time by the selling securityholders |
|
| September 2, 2021 |
As filed with the Securities and Exchange Commission on September 1, 2021 Table of Contents As filed with the Securities and Exchange Commission on September 1, 2021 Registration No. |
|
| September 2, 2021 |
September 2, 2021 VIA EDGAR Mr. Larry Spirgel Mr. Matthew Crispino Division of Corporation Finance Office of Technology U.S. Securities & Exchange Commission 100 F Street, NE Washington, D.C. 20549 RE: Evolv Technologies Holdings, Inc. (the ?Company?) Registration Statement on Form S-1 (File No. 333-258748) (the ?Registration Statement?) Dear Messrs. Spirgel and Crispino: The Company hereby reques |
|
| August 16, 2021 |
Exhibit 99.3 EVOLV TECHNOLOGIES, INC. CONSOLIDATED BALANCE SHEETS (In thousands, except share and per share amounts) (Unaudited) June 30, December 31, 2021 2020 Assets Current assets: Cash and cash equivalents $ 9,963 $ 4,704 Restricted cash 400 $ - Accounts receivable, net 2,799 1,401 Inventory 3,869 2,742 Current portion of commission asset 842 562 Prepaid expenses and other current assets 8,395 |
|
| August 16, 2021 |
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS OF EVOLV Exhibit 99.4 MANAGEMENT?S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS OF EVOLV You should read the following discussion and analysis of Evolv?s financial condition and results of operations together with our consolidated financial statements and the related notes appearing at Exhibit 99.3 of this Current Report on Form 8-K/A (the ?Form 8-K/A?) filed with the Securities |
|
| August 16, 2021 |
UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION Exhibit 99.2 UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION Capitalized terms used but not defined in this Exhibit 99.2 shall have the meanings ascribed to them in the Current Report on Form 8-K filed with the Securities and Exchange Commission (the ?SEC?) on July 22, 2021 and, if not defined in the Form 8-K, the Proxy Statement/Prospectus. The following unaudited pro forma condensed |
|
| August 16, 2021 |
Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) July 16, 2021 Evolv Technologies Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39417 84-4473840 (State or other jurisdiction of |
|
| August 16, 2021 |
Exhibit 99.1 Investor Relations: Brian Norris Vice President of Investor Relations [email protected] Public Relations: Fitz Barth Director of Communications [email protected] Evolv Technology Reports Strong Second Quarter Financial Results ? Company Issues Full Year Revenue Outlook of 375% Growth in 2021 ? ? Q2 Revenue of $4.5 million, up 590% year-over-year ? Q2 Total Contract |
|
| August 16, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 11, 2021 Evolv Technologies Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39417 84-4473840 (State or other jurisdiction of incorporation) ( |
|
| August 16, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q Table of Contents ? ? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 ? For the transition period from to ? Commission File Number: 001-40493 Evolv Technologies Holdings, Inc. |
|
| August 12, 2021 |
Power of Attorney (included on the signature page hereof). TABLE OF CONTENTS As filed with the Securities and Exchange Commission on August 12, 2021 Registration No. |
|
| August 6, 2021 |
8-K 1 tm2124319d18k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 4, 2021 Evolv Technologies Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39417 84-4473840 (State or other |
|
| July 26, 2021 |
EVLV / Evolv Technologies Holdings, Inc. Class A / Finback Evolv, LLC Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D UNDER THE SECURITIES EXCHANGE ACT OF 1934 EVOLV TECHNOLOGIES HOLDINGS, INC. (Name of Issuer) Class A Common Stock, par value $0.0001 per share (Title of Class of Securities) 30049H102 (CUSIP Number) George B. Huber Finback Evolv, LLC 200 Anastasia Avenue Suite 500 Coral Gables, FL 33134 (305) 416-2626 With a Copy |
|
| July 26, 2021 |
EX-99.3 2 finbackevolv13dex.htm JOINT FILING AGREEMENT Exhibit 99.3 JOINT FILING AGREEMENT In accordance with Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13D (including additional amendments thereto) with respect to the shares of Class A common stock, par value $0 |
|
| July 26, 2021 |
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13D (RULE 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(a) (Amendment No.)* Evolv Technologies Holdings, Inc. (Name of Issuer) Class A Common Stock, $0.0001 par value per share (Title of Class of Securities) 30049H102 (CUSIP Number) Spencer Punt |
|
| July 26, 2021 |
EXHIBIT 99.1 AGREEMENT Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13D need be filed with respect to the ownership by each of the undersigned of shares of stock of Evolv Technologies Holdings, Inc. EXECUTED this 26th day of July, 2021. GENERAL CATALYST GROUP V, L.P. By: |
|
| July 26, 2021 |
NewHold Investment Corp / General Catalyst GP V, LLC - SC 13D Activist Investment SC 13D UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. )* Evolv Technologies Holdings, Inc. (Name of Issuer) Class A Common Stock, $0.0001 par value (Title of Class of Securities) 651448102 (CUSIP Number) Christopher McCain General Catalyst Partners 20 University Road, 4th Floor, Cambridge, MA 02138 (617) |
|
| July 26, 2021 |
Exhibit 1 JOINT FILING AGREEMENT In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of them of a statement on Schedule 13D (including amendments thereto) with respect to the shares of Class A common stock, $0. |
|
| July 26, 2021 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. )* EVOLV TECHNOLOGIES HOLDINGS, INC. (Name of Issuer) Class A Common Stock, $0.0001 par value per share (Title of Class of Securities) 30049H102 (CUSIP Number) Peter Hebert Lux Capital Management, LLC 920 Broadway, 11th Floor New York, NY 10010 (646) 475-4385 with copies |
|
| July 23, 2021 |
EVLV / Evolv Technologies Holdings, Inc. Class A / Gates William H Iii - SC 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Evolv Technologies Holdings, Inc. (Name of Issuer) Class A Common Stock, $0.0001 par value (Title of Class of Securities) 30049H102 (CUSIP Number) July 16, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate |
|
| July 22, 2021 |
Exhibit 2.2 EXECUTION VERSION FIRST AMENDMENT TO AGREEMENT AND PLAN OF MERGER THIS FIRST AMENDMENT TO AGREEMENT AND PLAN OF MERGER (this ?Amendment?) is made as of June 5, 2021 (the ?Amendment Date?) by and among NewHold Investment Corp., a Delaware corporation (?Parent?), NHIC Sub Inc., a Delaware limited liability company and wholly-owned subsidiary of Parent (?Merger Sub?), and Evolv Technologi |
|
| July 22, 2021 |
Exhibit 21.1 Subsidiary Jurisdiction of Incorporation Evolv Technologies, Inc., dba Evolv Technology, Inc. Delaware Evolv NewHold Benefit LLC Delaware |
|
| July 22, 2021 |
EX-99.1 8 tm2122761d1ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Evolv Technology Publicly Listed on the NASDAQ Under Symbol EVLV NewHold Investment Corp. and Evolv Technology Complete Business Combination · Evolv is the global leader in weapons detection security screening, dedicated to making the world a safer place to work, learn and play by helping to protect innocent people from mass shootings and t |
|
| July 22, 2021 |
Amended and Restated Certificate of Incorporation. Exhibit 3.1 SECOND AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF NEWHOLD INVESTMENT CORP. NewHold Investment Corp. (the ?Corporation?), a corporation organized and existing under the General Corporation Law of the State of Delaware (the ?DGCL?), does hereby certify as follows: 1. The name of the Corporation is NewHold Investment Corp. The Corporation was incorporated under the name NewHold |
|
| July 22, 2021 |
UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION Exhibit 99.2 UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION Capitalized terms used but not defined in this Exhibit 99.2 shall have the meanings ascribed to them in the Current Report on Form 8-K (the ?Form 8-K?) filed with the Securities and Exchange Commission (the ?SEC?) on July 21, 2021 and, if not defined in the Form 8-K, the proxy statement/prospectus. The following unaudited pr |
|
| July 22, 2021 |
UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION Exhibit 99.2 UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION Capitalized terms used but not defined in this Exhibit 99.2 shall have the meanings ascribed to them in the Current Report on Form 8-K (the ?Form 8-K?) filed with the Securities and Exchange Commission (the ?SEC?) on July 21, 2021 and, if not defined in the Form 8-K, the proxy statement/prospectus. The following unaudited pr |
|
| July 22, 2021 |
EX-21.1 7 tm2122761d1ex21-1.htm EXHIBIT 21.1 Exhibit 21.1 Subsidiary Jurisdiction of Incorporation Evolv Technologies, Inc., dba Evolv Technology, Inc. Delaware Evolv NewHold Benefit LLC Delaware |
|
| July 22, 2021 |
Letter from WithumSmith+Brown PC to the U.S. Securities and Exchange Commission dated July 21, 2021. EX-16.1 6 tm2122761d3ex16-1.htm EXHIBIT 16.1 Exhibit 16.1 July 21, 2021 Office of the Chief Accountant Securities and Exchange Commission 100 F Street, NE Washington, D.C. 20549 Ladies and Gentlemen: We have read Evolv Technologies Holdings, Inc.’s (formerly known as NewHold Investment Corp.) statements included under Item 4.01 of its Form 8-K dated July 16, 2021. We agree with the statements conc |
|
| July 22, 2021 |
Letter from WithumSmith+Brown PC to the U.S. Securities and Exchange Commission dated July 21, 2021. Exhibit 16.1 July 21, 2021 Office of the Chief Accountant Securities and Exchange Commission 100 F Street, NE Washington, D.C. 20549 Ladies and Gentlemen: We have read Evolv Technologies Holdings, Inc.?s (formerly known as NewHold Investment Corp.) statements included under Item 4.01 of its Form 8-K dated July 16, 2021. We agree with the statements concerning our Firm under Item 4.01, in which we |
|
| July 22, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): July 16, 2021 Evolv Technologies Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39417 84-4473840 (State or other jurisdiction of incorporation) (Co |
|
| July 22, 2021 |
Exhibit 2.2 EXECUTION VERSION FIRST AMENDMENT TO AGREEMENT AND PLAN OF MERGER THIS FIRST AMENDMENT TO AGREEMENT AND PLAN OF MERGER (this ?Amendment?) is made as of June 5, 2021 (the ?Amendment Date?) by and among NewHold Investment Corp., a Delaware corporation (?Parent?), NHIC Sub Inc., a Delaware limited liability company and wholly-owned subsidiary of Parent (?Merger Sub?), and Evolv Technologi |
|
| July 22, 2021 |
Exhibit 3.2 Amended and Restated Bylaws of Evolv Technologies Holdings, Inc. (a Delaware corporation) Table of Contents Page Article I - Corporate Offices 1 1.1 Registered Office 1 1.2 Other Offices 1 Article II - Meetings of Stockholders 1 2.1 Place of Meetings 1 2.2 Annual Meeting 1 2.3 Special Meeting 1 2.4 Notice of Business to be Brought before a Meeting. 2 2.5 Notice of Nominations for Elect |
|
| July 22, 2021 |
Exhibit 10.16 AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT THIS AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT (this ?Agreement?), dated as of July 16, 2021, is made and entered into by and among Evolv Technologies Holdings, Inc., a Delaware corporation (?Evolv?), NewHold Investment Corp., a Delaware corporation (the ?Company?), NewHold Industrial Technology Holdings LLC, a Delaware limi |
|
| July 22, 2021 |
EX-3.2 4 tm2122761d3ex3-2.htm EXHIBIT 3.2 Exhibit 3.2 Amended and Restated Bylaws of Evolv Technologies Holdings, Inc. (a Delaware corporation) Table of Contents Page Article I - Corporate Offices 1 1.1 Registered Office 1 1.2 Other Offices 1 Article II - Meetings of Stockholders 1 2.1 Place of Meetings 1 2.2 Annual Meeting 1 2.3 Special Meeting 1 2.4 Notice of Business to be Brought before a Meet |
|
| July 22, 2021 |
EX-99.1 8 tm2122761d3ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Evolv Technology Publicly Listed on the NASDAQ Under Symbol EVLV NewHold Investment Corp. and Evolv Technology Complete Business Combination · Evolv is the global leader in weapons detection security screening, dedicated to making the world a safer place to work, learn and play by helping to protect innocent people from mass shootings and t |
|
| July 22, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): July 16, 2021 Evolv Technologies Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39417 84-4473840 (State or other jurisdiction of incorporation) (Co |
|
| July 22, 2021 |
Amended and Restated Certificate of Incorporation EX-3.1 3 tm2122761d1ex3-1.htm EXHIBIT 3.1 Exhibit 3.1 SECOND AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF NEWHOLD INVESTMENT CORP. NewHold Investment Corp. (the “Corporation”), a corporation organized and existing under the General Corporation Law of the State of Delaware (the “DGCL”), does hereby certify as follows: 1. The name of the Corporation is NewHold Investment Corp. The Corporatio |
|
| July 22, 2021 |
EX-10.16 5 tm2122761d1ex10-16.htm EXHIBIT 10.16 Exhibit 10.16 AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT THIS AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of July 16, 2021, is made and entered into by and among Evolv Technologies Holdings, Inc., a Delaware corporation (“Evolv”), NewHold Investment Corp., a Delaware corporation (the “Company”), NewHold Ind |
|
| July 21, 2021 |
Financial Statements and Exhibits, Other Events, Submission of Matters to a Vote of Security Holders United States SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 July 15, 2021 Date of Report (Date of earliest event reported) Evolv Technologies Holdings, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 001-39417 84-4473840 (State or other jurisdiction of incorporation) (Com |
|
| July 21, 2021 |
NewHold Investment Corp. Shareholders Approve Business Combination with Evolv Technology Exhibit 99.1 July 15, 2021 NewHold Investment Corp. Shareholders Approve Business Combination with Evolv Technology WALTHAM, Mass. & NEW YORK-(BUSINESS WIRE)- NewHold Investment Corp. (NASDAQ: NHIC, “NewHold”), a publicly traded special purpose acquisition company, announced that its shareholders have approved all proposals related to the previously announced business combination (the “Business Co |
|
| June 29, 2021 |
Filed by NewHold Investment Corp. Pursuant to Rule 425 under the Securities Act of 1933 and Rule 14a-12 under the Securities Exchange Act of 1934 Commission File No. 001-39417 Subject Company: Evolv Technologies, Inc. 2 3 Important Information for Investors and Stockholders This document relates to a proposed transaction between NewHold and Evolv. This document does not constitute an offer to sell |
|
| June 28, 2021 |
Filed by NewHold Investment Corp. Pursuant to Rule 425 under the Securities Act of 1933 and Rule 14a-12 under the Securities Exchange Act of 1934 Commission File No. 001-39417 Subject Company: Evolv Technologies, Inc. NewHold Investment Corp. and Evolv Technology Announce Registration Statement Effectiveness and Scheduled Special Meeting to Approve Business Combination on July 15, 2021 WALTHAM, MA |
|
| June 28, 2021 |
PROPOSED MERGER YOUR VOTE IS VERY IMPORTANT 424B3 1 f424b30621newholdinv.htm FORM 424B3 Filed Pursuant to Rule 424(b)(3) Registration No. 333-255017 PROPOSED MERGER YOUR VOTE IS VERY IMPORTANT Dear Stockholders: You are cordially invited to attend the special meeting of the stockholders (the “Meeting”) of NewHold Investment Corp. (“NHIC”), which will be held at 8:00 a.m., Eastern time, on July 15, 2021. Due to the continuing public health c |
|
| June 24, 2021 |
[NEWHOLD LETTERHEAD] June 24, 2021 VIA EDGAR & TELECOPY Mr. Larry Spirgel Mr. Matthew Crispino Division of Corporation Finance Office of Technology U.S. Securities & Exchange Commission 100 F Street, NE Washington, D.C. 20549 RE: NewHold Investment Corp. (the ?Company?) Registration Statement on Form S-4 (File No. 333-255017) (the ?Registration Statement?) Dear Messrs. Spirgel and Crispino: The Co |
|
| June 21, 2021 |
Filed by NewHold Investment Corp. Filed by NewHold Investment Corp. Pursuant to Rule 425 under the Securities Act of 1933 and Rule 14a-12 under the Securities Exchange Act of 1934 Commission File No. 001-39417 Subject Company: Evolv Technologies, Inc. Evolv Technology to Enhance Security at the 121st U.S. Open Championship WALTHAM, Mass. June 17, 2021 - Evolv is transforming the physical security industry by providing the world?s |
|
| June 14, 2021 |
Filed by NewHold Investment Corp. Pursuant to Rule 425 under the Securities Act of 1933 and Rule 14a-12 under the Securities Exchange Act of 1934 Commission File No. 001-39417 Subject Company: Evolv Technologies, Inc. Evolv Technology ? Pre-Recorded Remarks: First Quarter 2021 Business Update Conference Call, June 10, 2021 C O R P O R A T E P A R T I C I P A N T S Peter George, Chief Executive Off |
|
| June 11, 2021 |
Filed by NewHold Investment Corp. Pursuant to Rule 425 under the Securities Act of 1933 and Rule 14a-12 under the Securities Exchange Act of 1934 Commission File No. 001-39417 Subject Company: Evolv Technologies, Inc. 2 3 4 5 Important Information for Investors and Stockholders This document relates to a proposed transaction between NewHold and Evolv. This document does not constitute an offer to |
|
| June 9, 2021 |
Consent of Merline Saintil to be named as a director. Exhibit 99.5 CONSENT TO BE NAMED AS A DIRECTOR Pursuant to Rule 438 promulgated under the Securities Act of 1933, as amended, I hereby consent to my being named in the Registration Statement on Form S-4 of NewHold Investment Corp., and all amendments thereto (the ?Registration Statement?) and any related prospectus filed pursuant to Rule 424 promulgated under the Securities Act of 1933, as amended |
|
| June 9, 2021 |
Amended and Restated Bylaws of Combined Company. EX-3.5 2 fs42021a2ex3-5newhold.htm AMENDED AND RESTATED BYLAWS OF COMBINED COMPANY Exhibit 3.5 Amended and Restated Bylaws of Evolv Technologies Holdings, Inc. (a Delaware corporation) Table of Contents Page Article I - Corporate Offices 1 1.1 Registered Office 1 1.2 Other Offices 1 Article II - Meetings of Stockholders 1 2.1 Place of Meetings 1 2.2 Annual Meeting 1 2.3 Special Meeting 1 2.4 Notic |
|
| June 9, 2021 |
Exhibit 2.1 EXECUTION VERSION FIRST AMENDMENT TO AGREEMENT AND PLAN OF MERGER THIS FIRST AMENDMENT TO AGREEMENT AND PLAN OF MERGER (this ?Amendment?) is made as of June 5, 2021 (the ?Amendment Date?) by and among NewHold Investment Corp., a Delaware corporation (?Parent?), NHIC Sub Inc., a Delaware limited liability company and wholly-owned subsidiary of Parent (?Merger Sub?), and Evolv Technologi |
|
| June 9, 2021 |
Consent of Alan Cohen to be named as a director. EX-99.3 12 fs42021a2ex99-3newhold.htm CONSENT OF ALAN COHEN TO BE NAMED AS A DIRECTOR Exhibit 99.3 CONSENT TO BE NAMED AS A DIRECTOR Pursuant to Rule 438 promulgated under the Securities Act of 1933, as amended, I hereby consent to my being named in the Registration Statement on Form S-4 of NewHold Investment Corp., and all amendments thereto (the “Registration Statement”) and any related prospect |
|
| June 9, 2021 |
United States SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 June 5, 2021 Date of Report (Date of earliest event reported) NewHold Investment Corp. (Exact Name of Registrant as Specified in its Charter) Delaware 001-39417 84-4473840 (State or other jurisdiction of incorporation) (Commission Fi |
|
| June 9, 2021 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits United States SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 June 5, 2021 Date of Report (Date of earliest event reported) NewHold Investment Corp. (Exact Name of Registrant as Specified in its Charter) Delaware 001-39417 84-4473840 (State or other jurisdiction of incorporation) (Commission Fi |
|
| June 9, 2021 |
Consent of David Orfao to be named as a director. EX-99.4 13 fs42021a2ex99-4newhold.htm CONSENT OF DAVID ORFAO TO BE NAMED AS A DIRECTOR Exhibit 99.4 CONSENT TO BE NAMED AS A DIRECTOR Pursuant to Rule 438 promulgated under the Securities Act of 1933, as amended, I hereby consent to my being named in the Registration Statement on Form S-4 of NewHold Investment Corp., and all amendments thereto (the “Registration Statement”) and any related prospec |
|
| June 9, 2021 |
EX-2.1 2 ea142412ex2-1newholdinvest.htm FIRST AMENDMENT TO THE AGREEMENT AND PLAN OF MERGER DATED AS OF JUNE 5, 2021, BY AND AMONG NEWHOLD INVESTMENT CORP., NHIC SUB INC. AND EVOLV TECHNOLOGIES, INC Exhibit 2.1 EXECUTION VERSION FIRST AMENDMENT TO AGREEMENT AND PLAN OF MERGER THIS FIRST AMENDMENT TO AGREEMENT AND PLAN OF MERGER (this “Amendment”) is made as of June 5, 2021 (the “Amendment Date”) b |
|
| June 9, 2021 |
EX-10.16 7 fs42021a2ex10-16newhold.htm FORM OF AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT BY AND AMONG NEWHOLD, EVOLV AND CERTAIN STOCKHOLDERS Exhibit 10.16 FORM OF AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT THIS AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of [], 2021, is made and entered into by and among Evolv Technologies Holdings, Inc., a Del |
|
| June 9, 2021 |
Consent of Michael Ellenbogen to be named as a director. Exhibit 99.2 CONSENT TO BE NAMED AS A DIRECTOR Pursuant to Rule 438 promulgated under the Securities Act of 1933, as amended, I hereby consent to my being named in the Registration Statement on Form S-4 of NewHold Investment Corp., and all amendments thereto (the ?Registration Statement?) and any related prospectus filed pursuant to Rule 424 promulgated under the Securities Act of 1933, as amended |
|
| June 9, 2021 |
Consent of Bilal Zuberi to be named as a director. EX-99.9 18 fs42021a2ex99-9newhold.htm CONSENT OF BILAL ZUBERI TO BE NAMED AS A DIRECTOR Exhibit 99.9 CONSENT TO BE NAMED AS A DIRECTOR Pursuant to Rule 438 promulgated under the Securities Act of 1933, as amended, I hereby consent to my being named in the Registration Statement on Form S-4 of NewHold Investment Corp., and all amendments thereto (the “Registration Statement”) and any related prospe |
|
| June 9, 2021 |
Consent of Mahesh Saptharishi to be named as a director. Exhibit 99.6 CONSENT TO BE NAMED AS A DIRECTOR Pursuant to Rule 438 promulgated under the Securities Act of 1933, as amended, I hereby consent to my being named in the Registration Statement on Form S-4 of NewHold Investment Corp., and all amendments thereto (the “Registration Statement”) and any related prospectus filed pursuant to Rule 424 promulgated under the Securities Act of 1933, as amended |
|
| June 9, 2021 |
Specimen Class A Common Stock Certificate of Evolv Technologies Holdings, Inc. Exhibit 4.4 NUMBER C- SHARES SEE REVERSE FOR CERTAIN DEFINITIONS CUSIP Evolv Technologies Holdings, Inc. INCORPORATED UNDER THE LAWS OF THE STATE OF DELAWARE This Certifies that is the owner of FULLY PAID AND NON-ASSESSABLE SHARES OF THE PAR VALUE OF $0.0001 EACH OF THE CLASS A COMMON STOCK OF Evolv Technologies Holdings, Inc. (THE ?COMPANY?) transferable on the books of the Company in person or b |
|
| June 9, 2021 |
Form of 2021 Evolv Technologies Holdings, Inc. Employee Stock Purchase Plan. As filed with the U.S. Securities and Exchange Commission on June 9, 2021 Registration No. 333-255017 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 2 TO Form S-4 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 NEWHOLD INVESTMENT CORP. (Exact name of registrant as specified in its charter) Delaware 6770 (State or other jurisdiction of incorporation or |
|
| June 9, 2021 |
Giovanni Caruso Partner 345 Park Avenue Direct 212.407.4866 New York, NY 10154 Main 212.407.4000 Fax 212.937.3943 [email protected] Via Edgar June 9, 2021 Larry Spirgel Matthew Crispino Division of Corporation Finance Office of Technology U.S. Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Re: NewHold Investment Corp. Amendment No. 1 to Registration Statement on Form S |
|
| June 9, 2021 |
Form of Indemnification Agreement. Exhibit 10.10 EVOLV TECHNOLOGIES HOLDINGS, INC. INDEMNIFICATION AGREEMENT THIS INDEMNIFICATION AGREEMENT (the ?Agreement?) is made and entered into as of , 2021 by and between Evolv Technologies Holdings, Inc., a Delaware corporation (the ?Company?), and [a member of the Board of Directors] / [an officer] of the Company (?Indemnitee?). This Agreement supersedes and replaces any and all previous ag |
